HR18042
N/A
Report date: 2026/01/26 20:01:04
NME
Base Information
Drug NameHR18042
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Imrecoxib
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesChengdu Suncadia Medicine Co LtdSuzhou Suncadia Biopharmaceuticals Co LtdJiangsu Hengrui Medicine Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A